Brand New Medical Study
Cutting edge potential treatment for Rheumatoid Arthritis
In order to be considered to take part in the study, you’ll need to meet all of the following:
✔️ 18 to 75 years old
✔️ Have been diagnosed with Rheumatoid Arthritis for 6 months or more
✔️ Have been on oral methotrexate therapy for at least 3 months
If that sounds like you, we would like to invite you to take part in our latest study investigating a potential treatment!
Click here or scroll down to learn about this study's inclusion criteria ⬇️
📝 Registration Form
If you take part in the research study you will receive:
Reimbursement of costs
For out-of-pocket expenses, such as travel and meals
Free study-related medical care
You may gain access to new potential treatments, before they are widely available
Advance Medical Science
Do your part to help advance breakthroughs in clinical research.
🏥 Study Guide
Who can take part in this study?
In order to be eligible to participate in the study, you must meet all of the following:
- You are aged between 18 and 75 Years old
- You have a body mass index (BMI) of between 18 and 32 click here for a BMI calculator
- You have been diagnosed with Rheumatoid arthritis (RA) 6 months ago or more
How long will the study take?
If you agree to take part, and the study is suitable for you, your participation in the study is expected to last up to 42 days. This includes 6 overnight hospital stays during the 14 day treatment period.
The study site is located in Christchurch but participants may be relocated from anywhere in NZ, at the trial sponsor’s expense.
What is Rheumatoid Arthritis?
Rheumatoid arthritis (RA) is an autoimmune disease that causes pain and swelling of the joints. The normal role of your body’s immune system is to fight off infections to keep you healthy. Autoimmune diseases cause your immune system to attack your own healthy tissues.
During RA, the immune system targets the lining of the joints, causing inflammation and joint damage. RA usually affects the smaller joints, such as the joints in the hands and feet. However larger joints such as the hips and knees can also be affected.
How will I be monitored throughout the study?
Regular safety assessments will be taken during your stay including monitoring of adverse events, vital signs (blood pressure, pulse rate, and oral temperature), clinical laboratory findings, blood samples, 12-lead ECGs, and physical examinations.
What if I have other questions about the study?
We are here for you! Click or tap this button to send an email to our Patient Experience team: